Bioethics News

First US-Based Group to Edit Human Embryos Brings Practice Closer to Clinic

The ethical and practical debates over using the DNA-editing method CRISPR to alter human embryos just got less hypothetical. A week after the news leaked out, a US-based team has published the first rigorous demonstration that CRISPR can efficiently repair a gene defect in human embryos without introducing new mutations elsewhere. With comments from our Jeffrey Kahn

Source: Bioethics Bulletin by the Berman Institute of Bioethics.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.